2026 European Pharmaceutical Capex Outlook – France, Belgium & the Netherlands
The European pharmaceutical capex outlook for 2026 is more restrained than twelve months ago, but there remains meaningful opportunity for suppliers of capital equipment and machinery. While the exceptional conditions of 2024 have eased, the market continues to generate a steady flow of investment, with regional nuances shaping where the best commercial prospects lie. European Continue reading
This entry was posted in Analysis on February 12, 2026